Graves Disease: A Successful Salpingectomy and Cesarean Section
DOI:
https://doi.org/10.17140/whoj.2024.v10.i01.pp01-02.7Keywords:
Given the fact that poorly controlled thyrotoxicosis is related to several maternal and fetal complicationsAbstract
As illustrated in Figure 1, the
scan shows uniform isotope uptake evident of the right and left
lobes of the thyroid gland with no focal areas of decreased or
increased uptake. The radiologic impression significantly increased
the isotope uptake at both 5-hours and 23-hours that is consistent with the graves disease. After the detailed discussion about
the probable results with the patient, high-risk obstetric surgery
was planned. A low transverse C-section was performed along with
bilateral salpingectomy. The patient tolerated the procedure well
with no anesthetic complications. Upon the birth of the neonate,
there were no complications reported after assessment by an inhouse neonatologist. Thus, making this high-risk surgery a success.
Graves disease affects 1 out of every 1000 women and the unique
steps taken during this case has made it successful and noteworthy
References
Baes F. Nuclear Medicine and the Pregnant Patient Q&A. Web Submit your article to this journal | https://openventio.org/submit-manuscript/ 2 Sanni R et al site. https://hps.org/physicians/nuclear_medicine_pregnant_pa-tient_qa.html#Q3. Accessed November 10, 2019.
DeGroot LJ. Graves’ Disease and the Manifestations of Thyro-toxicosis. In: Feingold KR, Anawalt B, Boyce A, et al., eds. Endo-text [Internet]. South Dartmouth (MA), USA: MDText.com, Inc; 2000.
Grigoriu C, Cezar C, Grigoras M, et al. Management of hyper-thyroidism in pregnancy. J Med Life. 2008; 1(4): 390-396.
Linardi A, Michou E, Ilias I, et al. Resistant thyrotoxicosis due to Graves’ Disease in pregnancy: Case report and review of the literature. Cureus. 2018; 10(8): e3232. doi: 10.7759/cureus.3232
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Women's Health (WH) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.